Benzinga | Aug 12, 2021 07:28AM EDT

Zentalis Pharmaceuticals Q2 EPS $1.34 Up From $(0.78) YoY

Zentalis Pharmaceuticals (NASDAQ:ZNTL) reported quarterly earnings of $1.34 per share. This is a 271.79 percent increase over losses of $(0.78) per share from the same period last year.